PlainRecalls
FDA Drug Moderate Class II Terminated

Carbidopa and Levodopa Tablets USP, 25mg/100mg, 1000 count bottle, Rx only, Manufactured in Israel by Teva Pharmaceutical IND, LTD., Jeruselem, Israel, for Teva Pharmaceuticals USA, Sellersville, PA, NDC 0093-0293-10

Reported: August 20, 2014 Initiated: June 5, 2014 #D-1538-2014

Product Description

Carbidopa and Levodopa Tablets USP, 25mg/100mg, 1000 count bottle, Rx only, Manufactured in Israel by Teva Pharmaceutical IND, LTD., Jeruselem, Israel, for Teva Pharmaceuticals USA, Sellersville, PA, NDC 0093-0293-10

Reason for Recall

Failed Tablet/Capsule Specifications: Teva is recalling one lot of Carbidopa and Levodopa Tablets USP, 25mg/100mg due to the potential for superpotent tablets.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
3881bottles
Distribution
Nationwide
Location
North Wales, PA

Frequently Asked Questions

What product was recalled?
Carbidopa and Levodopa Tablets USP, 25mg/100mg, 1000 count bottle, Rx only, Manufactured in Israel by Teva Pharmaceutical IND, LTD., Jeruselem, Israel, for Teva Pharmaceuticals USA, Sellersville, PA, NDC 0093-0293-10. Recalled by Teva Pharmaceuticals USA. Units affected: 3881bottles.
Why was this product recalled?
Failed Tablet/Capsule Specifications: Teva is recalling one lot of Carbidopa and Levodopa Tablets USP, 25mg/100mg due to the potential for superpotent tablets.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 20, 2014. Severity: Moderate. Recall number: D-1538-2014.